Pacer Advisors, Inc. Vaxcyte, Inc. Transaction History

Pacer Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$60.06 - $78.77 $3,003 - $3,938	-50 Reduced 8.49%	539 $40,000
Q1 2024 May 10, 2024	BUY	$59.79 - $81.05 $35,216 - $47,738	589 New	589 $40,000
Q2 2021 Jul 21, 2021	SELL	$16.45 - $24.06 $34,906 - $51,055	-2,122 Closed	0 $0
Q1 2021 Apr 05, 2021	BUY	$18.66 - $29.16 $15,861 - $24,786	850 Added 66.82%	2,122 $42,000
Q4 2020 Jan 20, 2021	BUY	$26.57 - $51.74 $33,797 - $65,813	1,272 New	1,272 $34,000

352

122M

775K

433K

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $5.25B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.